Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03736759 · ClinicalTrials.gov registry record · NA
Resistance Exercise to Improve Flu Vaccine for Older Adults
A NA study of Influenza, Human, sponsored by University of Houston.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT03736759: Completed NA study of Influenza, Human, sponsored by University of Houston.
NCT03736759 is a NA study of Influenza, Human that has completed, run by University of Houston. The registered enrollment target is 29 participants, below the 16,222-participant average among 18 other Influenza, Human trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03736759, a NA study of Influenza, Human, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates whether resistance exercise will improve immune responses to the seasonal influenza vaccine in older adults. One third of the participants will perform exercise in the arm that receives the vaccine, one third of the participants will perform the same exercise in the arm that does not receive the vaccine, and one third will only receive the vaccine.
Primary Outcome
The change in the peripheral blood mononuclear cell response to overnight ex vivo culture with the seasonal quadrivalent vaccine detected via Interferon-gamma ELISPOT will be calculated from baseline at 6 weeks post-vaccine
Conditions Studied
Interventions
- BEHAVIORAL Exercise
Study Locations (1)
Texas
- University of Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2018-10-08 |
| Est. Completion | 2021-04-01 |
| Phase | NA |
What the finished NCT03736759 record still lists
NCT03736759 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 16,222-participant average among 18 other Influenza, Human trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Influenza, Human appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.
NCT03736759 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03736759 about?
NCT03736759 is a clinical study titled "Resistance Exercise to Improve Flu Vaccine for Older Adults". This study evaluates whether resistance exercise will improve immune responses to the seasonal influenza vaccine in older adults. One third of the participants will perform exercise in the arm that receives the vaccine, one third of the participants will perform the same exercise in the arm that doe...
What is the current status of trial NCT03736759?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2018-10-08. Estimated completion is 2021-04-01.
What conditions does trial NCT03736759 study?
This clinical trial studies the following conditions: Influenza, Human.
What interventions are being tested in trial NCT03736759?
The interventions under investigation include: Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03736759?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03736759 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza, Human
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03736759's enrollment target sits among peer trials
29 17th of 18 higher than 2 of 18 other Influenza, Human trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Influenza, Human trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mail Outreach To Increase Vaccination Acceptance Through Engagement
COMPLETED · NA
-
A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above
RECRUITING · Phase 2
-
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults
RECRUITING · Phase 4
-
Flu Infection at UPHS
RECRUITING
-
A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older
ACTIVE NOT RECRUITING · Phase 2
-
A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI